← Evidence map

ArticleInternational journal of hematology2026

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.

Noriyoshi Iriyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group. | OpenQuestion